Rising Demand for UK Long-Acting Bronchodilator Market Key Players, Growth Analysis during 2019-2025

UK long-acting bronchodilator market is anticipated to grow at a substantial rate of around 1.5% during the forecast period. Inhalers are used for providing medication to the patients through the lungs. These are used for the treatment of the patient from asthma attacks and other respiratory ailments. As the prevalence of asthma and other diseases increases across UK, the demand for long-acting bronchodilators is also expected to increase for treatment purposes. As per the International Monetary Fund GDP of the country was $2.9 trillion in 2017. UK comprises England, Scotland, Wales and Northern Ireland. The total population of the country in 2017 was 65 million, out of which about 18% are of the geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by the government and people can be forecast in the near future.

To Request a Sample of our Report on UK Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/uk-long-acting-bronchodilator-market

UK long-acting bronchodilator market is segmented on the basis of route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, nasal, parenteral, and inhalation. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the country and rising demand for its various treatment solutions. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of UK Long-Acting Bronchodilator Market is Available @ https://www.omrglobal.com/industry-reports/uk-long-acting-bronchodilator-market

UK Long-Acting Bronchodilator Market Segmentation

By Route of Administration

· Oral

· Nasal

· Parenteral

· Inhalation

By Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Company Profiles

· Adamis Pharmaceuticals Corp.

· AstraZeneca PLC

· Boehringer Ingelheim International GmbH

· GlaxoSmithKline PLC

· Novartis AG

· ResMed Corp.

· Pulmatrix Inc.

· Savara, Inc.

· Sunovion Pharmaceuticals

· Teva Pharmaceuticals Industries Ltd.

· Vitalograph Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.